Humana, Inc. Hits New 52-Week High at $356.01, Showcasing Strong Growth

Humana, Inc., a prominent player in the healthcare services industry, has reached a significant milestone by hitting a new 52-week high of USD 356.01 on June 8, 2026. This achievement underscores the company's resilience and performance in a competitive market. Over the past year, Humana's stock has shown a modest increase of 1.9%, contrasting with the S&P 500's robust performance of 23.42%. The company's market capitalization stands at USD 32,156 million, classifying it as a mid-cap entity. Humana's price-to-earnings (P/E) ratio is currently at 27.00, reflecting its valuation relative to earnings. Additionally, the company offers a dividend yield of 1.60%, providing a return to its shareholders. With a debt-to-equity ratio of -0.42 and a return on equity of 6.81%, Humana demonstrates a solid financial position. The price-to-book ratio is recorded at 1.82, indicating the market's valuation of the company's assets. The stock's previous 52-week low was USD 163.11, highlighting the significant upward movement in its price.